A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Clinical trial NCT05433584 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05433584
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2025-10-21
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.